文献速递血栓与止血贫血与红细胞疾病

低血管性血友病因子相关月经过多的青少年出血谱与严重程度

The spectrum and severity of bleeding in adolescents with low von Willebrand factor-associated heavy menstrual bleeding.
PubMed 文献 · Blood Adv · 2020-01-01

该多中心单臂观察性队列研究纳入月经过多且低血管性血友病因子(VWF)的青春期女性,描述出血表型、月经过多严重程度及相关并发症。113例中94%有显著出血表型,常见皮肤黏膜出血、术后出血和严重月经过多,并发症包括缺铁、贫血、输血和住院;48%需联合治疗,三分之一治疗后无改善。

要点

  • 低VWF相关月经过多的青少年中94%出血评估工具(BAT)评分>2,90%月经过多领域评分≥2。
  • 出血并发症包括缺铁60%、贫血21%、输血12%、住院10%。
  • 48%需激素/止血联合治疗,三分之一治疗后无改善。

核心结论

  • 低VWF的青春期女性有显著出血表型及相关并发症,作者认为值得关注及时诊断、适当治疗和预防并发症。

研究设计与样本

  • 多中心单臂观察性队列研究,纳入月经初潮后、年龄<21岁、月经过多(PBAC评分>100)且低VWF(2次VWF活性≥30且≤50 IU/dL)的女性,排除其他出血性疾病。
  • 共113例符合入选标准,2例被排除。
  • 临床表型数据包括PBAC和出血评估工具(BAT)评分、实验室数据及月经过多管理/结局细节。
  • 人口学和临床特征以中位数(最小值/最大值)或频率(百分比)汇总,组间比较采用Wilcoxon秩和检验或Fisher精确检验。

主要发现

  • 94%有显著出血表型(BAT评分>2),以皮肤黏膜出血(32%-44%)、术后/手术出血(15%)和严重月经过多(BAT月经过多领域评分≥2;90%)为主。
  • 出血并发症包括缺铁(60%)、贫血(21%)、输血(12%)和住院(10%)。
  • 受试者中去氨加压素激发试验反应良好且持久。
  • 48%需联合治疗(激素/止血)治疗月经过多,三分之一尽管治疗仍未改善。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Low von Willebrand factor (VWF) in adults is associated with significant bleeding, most notably heavy menstrual bleeding (HMB) and postpartum hemorrhage, although this has not been characterized in adolescents. The objectives of this analysis of a multicenter single arm observational cohort study in adolescents with low VWF-associated HMB were to describe the bleeding phenotype, HMB severity, and related complications. Eligibility criteria included postmenarchal females <21 years of age with HMB (Pictorial Blood Assessment Chart [PBAC] score >100) and low VWF (2 values of VWF activity ≥30 and ≤50 IU/dL). Patients diagnosed with other bleeding disorders were ineligible. Clinical phenotype data, including PBAC and Bleeding Assessment Tool (BAT) scores, laboratory data, and HMB management/outcome details, were extracted. Patient demographics and clinical characteristics were summarized as medians with minimum/maximum values or frequencies with percentages. Groups were compared using a Wilcoxon rank-sum test or Fisher's exact test. A total of 113 patients met inclusion criteria, and 2 were excluded. Ninety four percent had a significant bleeding phenotype (BAT score >2), with predominantly mucocutaneous bleeding (32%-44%), postprocedural/surgical bleeding (15%), and severe HMB (BAT HMB domain score ≥2; 90%). Bleeding complications included iron deficiency (60%), anemia (21%), transfusion (12%), and hospitalization (10%). Desmopressin challenge response in subjects tested was good and sustained. Several (48%) required combined therapy for HMB (hormonal/hemostatic), and one third did not show improvement despite therapy. Our results suggest that adolescent females with low VWF have a significant bleeding phenotype and resultant complications warranting a focus on prompt diagnosis, appropriate therapy, and prevention of complications.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Srivaths L, Minard CG, O'Brien SH, et al. The spectrum and severity of bleeding in adolescents with low von Willebrand factor-associated heavy menstrual bleeding. Blood Adv. 2020. PMID: 32663297. doi:10.1182/bloodadvances.2020002081

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。